tiprankstipranks
Advertisement
Advertisement

VSTM Stock Latest News

Verastem Shareholders Back Board, Executive Pay and Plans
Company AnnouncementsVerastem Shareholders Back Board, Executive Pay and Plans
4d ago
8K
VSTM
Verastem appoints Michael Bailey to board of directors
PremiumThe Fly
Verastem appoints Michael Bailey to board of directors
4d ago
VSTM
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
6d ago
WVE
REAX
Verastem price target lowered to $14 from $16 at Mizuho
PremiumThe Fly
Verastem price target lowered to $14 from $16 at Mizuho
16d ago
VSTM
Verastem Inc Earnings Call Highlights Growth And Risk
PremiumCompany Announcements
Verastem Inc Earnings Call Highlights Growth And Risk
22d ago
VSTM
Verastem price target lowered to $18 from $19 at BTIG
PremiumThe FlyVerastem price target lowered to $18 from $19 at BTIG
22d ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
Premium
The Fly
Verastem price target raised to $18 from $16 at Alliance Global
22d ago
VSTM
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
Premium
The Fly
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
23d ago
VSTM
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
PremiumCompany Announcements
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
23d ago
8K
VSTM
VSTM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VSTM Upcoming Earnings Report: What to Expect?
25d ago
VSTM
Verastem announces launch of Reimagine Recurrent LGSOC campaign
PremiumThe Fly
Verastem announces launch of Reimagine Recurrent LGSOC campaign
1M ago
VSTM
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
PremiumRatings
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
1M ago
VSTM
3 Best Stocks to Buy Today, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, According to Top Analysts
2M ago
BBOT
VSTM
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
Premium
Ratings
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
2M ago
VSTM
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
Premium
The Fly
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
2M ago
VSTM
Verastem assumed with a Buy at Jefferies
PremiumThe Fly
Verastem assumed with a Buy at Jefferies
2M ago
VSTM
Verastem management to meet with Cantor
PremiumThe Fly
Verastem management to meet with Cantor
2M ago
VSTM
Verastem assumed with a Buy at BTIG
PremiumThe Fly
Verastem assumed with a Buy at BTIG
3M ago
VSTM
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
PremiumRatings
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
3M ago
VSTM
Verastem Earnings Call: Early Momentum, Long Runway Risks
PremiumCompany AnnouncementsVerastem Earnings Call: Early Momentum, Long Runway Risks
3M ago
VSTM
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
Premium
Ratings
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
3M ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
Premium
The Fly
Verastem price target raised to $18 from $16 at Alliance Global
3M ago
VSTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >